|
Name |
5-[(4-Chloro-3-methylphenoxy)methyl]-2-furoic acid
|
Molecular Formula | C13H11ClO4 | |
IUPAC Name* |
5-[(4-chloro-3-methylphenoxy)methyl]furan-2-carboxylic acid
|
|
SMILES |
CC1=C(C=CC(=C1)OCC2=CC=C(O2)C(=O)O)Cl
|
|
InChI |
InChI=1S/C13H11ClO4/c1-8-6-9(2-4-11(8)14)17-7-10-3-5-12(18-10)13(15)16/h2-6H,7H2,1H3,(H,15,16)
|
|
InChIKey |
QTABSYVYXVDOQN-UHFFFAOYSA-N
|
|
Synonyms |
406470-55-1; 5-[(4-Chloro-3-methylphenoxy)methyl]-2-furoic acid; 5-[(4-chloro-3-methylphenoxy)methyl]furan-2-carboxylic acid; 5-((4-Chloro-3-methylphenoxy)methyl)furan-2-carboxylic acid; 5-(4-Chloro-3-methylphenoxymethyl)-furan-2-carboxylic acid; 5-(4-chloro-3-methylphenoxymethyl)furan-2-carboxylic acid; Oprea1_125313; DTXSID701191009; ZINC133376; Furane-2-carboxylic acid, 5-(4-chloro-3-methylphenoxymethyl)-; BBL037850; MFCD02090846; STK346652; AKOS000206023; UNM-0000305931; CS-0262685; UNM000011075201; EN300-83480; AK-968/41170346; 5-[(4-Chloro-3-methylphenoxy)methyl]-2-furoic acid #; 5-((4-Chloro-3-methylphenoxy)methyl)furan-2-carboxylicacid; 5-(4-chloro-3-methyl-phenoxymethyl)-furan-2-carboxylic acid; 5-[(4-Chloro-3-methylphenoxy)methyl]-2-furancarboxylic acid
|
|
CAS | 406470-55-1 | |
PubChem CID | 580495 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 266.67 | ALogp: | 3.3 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 59.7 | Aromatic Rings: | 2 |
Heavy Atoms: | 18 | QED Weighted: | 0.899 |
Caco-2 Permeability: | -4.621 | MDCK Permeability: | 0.00001490 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.004 |
Human Intestinal Absorption (HIA): | 0.005 | 20% Bioavailability (F20%): | 0.004 |
30% Bioavailability (F30%): | 0.431 |
Blood-Brain-Barrier Penetration (BBB): | 0.078 | Plasma Protein Binding (PPB): | 98.95% |
Volume Distribution (VD): | 0.383 | Fu: | 1.48% |
CYP1A2-inhibitor: | 0.595 | CYP1A2-substrate: | 0.514 |
CYP2C19-inhibitor: | 0.302 | CYP2C19-substrate: | 0.059 |
CYP2C9-inhibitor: | 0.654 | CYP2C9-substrate: | 0.694 |
CYP2D6-inhibitor: | 0.029 | CYP2D6-substrate: | 0.365 |
CYP3A4-inhibitor: | 0.038 | CYP3A4-substrate: | 0.221 |
Clearance (CL): | 1.681 | Half-life (T1/2): | 0.78 |
hERG Blockers: | 0.264 | Human Hepatotoxicity (H-HT): | 0.41 |
Drug-inuced Liver Injury (DILI): | 0.972 | AMES Toxicity: | 0.122 |
Rat Oral Acute Toxicity: | 0.306 | Maximum Recommended Daily Dose: | 0.025 |
Skin Sensitization: | 0.049 | Carcinogencity: | 0.861 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.505 |
Respiratory Toxicity: | 0.11 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000748 | 0.400 | D08IFL | 0.360 | ||||
ENC003372 | 0.375 | D04YMH | 0.329 | ||||
ENC004623 | 0.343 | D09SOA | 0.316 | ||||
ENC001364 | 0.329 | D0DJ1B | 0.311 | ||||
ENC001510 | 0.317 | D0R1RS | 0.308 | ||||
ENC001515 | 0.311 | D0MN9K | 0.304 | ||||
ENC004474 | 0.308 | D05FTJ | 0.299 | ||||
ENC005266 | 0.306 | D05CKR | 0.289 | ||||
ENC005265 | 0.306 | D0PQ3G | 0.289 | ||||
ENC005264 | 0.297 | D0VB0U | 0.288 |